Back to Journals » Core Evidence » Volume 6

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Total article views   Abstract views HTML views PDF downloads Totals
13,900 Dovepress* 8,368 740+ 4,579 9,108
PubMed Central* 15 4,777 1,402 4,792
Totals 8,383 5,517 5,981 13,900
*Since 4 April 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar